文献速递免疫规划传染病防控与疫情报告

南非2型脊髓灰质炎病毒免疫缺口的估计

Estimation of the poliovirus type 2 immunity gap in South Africa.
PubMed 文献 · Vaccine · 2024-07-04

本研究利用2017至2022年南非52个区的灭活脊髓灰质炎病毒疫苗(IPV)接种剂量、活产数和人口规模数据,结合IPV一至四剂效力值,估计出生儿童对2型脊髓灰质炎病毒(PV2)的易感性,并与零剂次儿童(ZDC)比较。结果显示各区PV2易感性高度异质,5岁以下儿童中约30%至不足4%,易感性估计持续高于ZDC。

要点

  • 2022年底南非52个区5岁以下儿童PV2易感性从约30%到不足4%不等,地区差异大。
  • 全国ZDC从2017年155168例降至2021年108593例,2022年回升至127102例。
  • 本研究PV2易感性估计持续高于ZDC,但两者在地区风险排序上基本一致。

核心结论

  • 南非各区对PV2的易感性高度异质,本方法比零剂次儿童更全面反映PV2易感性,两者在地区风险排序上基本一致。

研究设计与样本

  • 使用2017至2022年各区IPV年接种剂量、活产数和人口规模数据,对缺失接种数据插补,采用灵活剂量分布假设和IPV一至四剂效力值,按出生年份计算易感和免疫儿童数,并与WUENIC报告的ZDC比较验证。

主要发现

  • 截至2022年底,南非52个区PV2易感性高度异质;5岁以下儿童中,Xhariep区31.9%、Ekurhuleni区30.1%、Central Karoo区29.8%,Sarah Baartman区1.9%、Buffalo City区2.1%、eThekwini区3.2%。
  • 全国ZDC从2017年155168例(152737-158523)降至2021年108593例,2022年升至127102例,趋势与WUENIC数据一致。
  • 本研究的易感性估计在整个时间段内持续高于ZDC。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the context of polio eradication efforts, accurate assessment of vaccination programme effectiveness is essential to public health planning and decision making. Such assessments are often based on zero-dose children, estimated using the number of children who did not receive the first dose of the Diphtheria-Tetanus-Pertussis containing vaccine as a proxy. Our study introduces a novel approach to directly estimate the number of children susceptible to poliovirus type 2 (PV2) and uses this approach to provide district-level estimates for South Africa of susceptible children born between 2017 and 2022. We used district-level data on annual doses of inactivated poliovirus vaccine (IPV) administered, live births, and population sizes, from 2017 through 2022. We imputed missing vaccination data, implemented flexible assumptions regarding dose distribution in the eligible population, and used estimated efficacy values for one, two, three, and four doses of IPV, to compute the number of susceptible and immune children by birth year. We validated our approach by comparing an intermediary output with zero-dose children (ZDC) estimated using data reported by WHO/UNICEF Estimates of National Immunization Coverage (WUENIC). Our results indicate high heterogeneity in susceptibility to PV2 across South Africa's 52 districts as of the end of 2022. In children under 5 years, PV2 susceptibility ranged from approximately 30 % in districts including Xhariep (31.9 %), Ekurhuleni (30.1 %), and Central Karoo (29.8 %), to less than 4 % in Sarah Baartman (1.9 %), Buffalo City (2.1 %), and eThekwini (3.2 %). Our susceptibility estimates were consistently higher than ZDC over the timeframe. We estimated that ZDC decreased nationally from 155,168 (152,737-158,523) in 2017 to 108,593 in 2021, and increased to 127,102 in 2022, a trend consistent with ZDC derived from data reported by WUENIC. While our approach provides a more comprehensive profile of PV2 susceptibility, our susceptibility and ZDC estimates generally agree in the ranking of districts according to risk.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Brown L, Bingham J, Pulliam J, et al. Estimation of the poliovirus type 2 immunity gap in South Africa. Vaccine. 2024. PMID: 38969540. doi:10.1016/j.vaccine.2024.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。